Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,027 | 2 | 86.8% |
| Food and Beverage | $612.99 | 13 | 13.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Butterfly Network, Inc. | $4,027 | 2 | $0 (2020) |
| Bioventus LLC | $224.87 | 4 | $0 (2021) |
| Stryker Corporation | $141.57 | 1 | $0 (2019) |
| Smith & Nephew, Inc. | $134.43 | 1 | $0 (2018) |
| DePuy Synthes Sales Inc. | $30.97 | 2 | $0 (2020) |
| Egalet US Inc | $24.42 | 2 | $0 (2017) |
| Horizon Pharma plc | $23.50 | 1 | $0 (2018) |
| Endo Pharmaceuticals Inc. | $21.67 | 1 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $11.56 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $26.45 | 1 | Bioventus LLC ($26.45) |
| 2020 | $2,044 | 2 | Butterfly Network, Inc. ($2,028) |
| 2019 | $2,141 | 2 | Butterfly Network, Inc. ($1,999) |
| 2018 | $331.99 | 5 | Bioventus LLC ($162.50) |
| 2017 | $96.95 | 5 | Bioventus LLC ($35.92) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2021 | Bioventus LLC | Exogen Ultrasound Bone Healing System (Device) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Not Applicable | ||||||
| 09/19/2020 | Butterfly Network, Inc. | Butterfly iQ (Device) | Consulting Fee | In-kind items and services | $2,028.00 | General |
| Category: class 2 device | ||||||
| 02/26/2020 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Sports Early Intervention | ||||||
| 08/14/2019 | Butterfly Network, Inc. | Butterfly iQ (Device) | Consulting Fee | In-kind items and services | $1,999.00 | General |
| Category: Ultrasound | ||||||
| 06/22/2019 | Stryker Corporation | TRITANIUM (Device) | Food and Beverage | Cash or cash equivalent | $141.57 | General |
| Category: HIPS | ||||||
| 05/21/2018 | Horizon Pharma plc | NO_PRODUCT (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: NONE | ||||||
| 05/17/2018 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $147.06 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 05/08/2018 | Smith & Nephew, Inc. | Coblation Wands (Device) | Food and Beverage | In-kind items and services | $134.43 | General |
| Category: Other Endoscopy | ||||||
| 02/21/2018 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: ORTHOPEDICS | ||||||
| 02/15/2018 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 11/30/2017 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Sports Early Intervention | ||||||
| 07/11/2017 | Egalet US Inc | SPRIX (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Pain Medicine | ||||||
| 04/20/2017 | Bioventus LLC | Exogen (Device) | Food and Beverage | In-kind items and services | $35.92 | General |
| Category: Not Applicable | ||||||
| 03/28/2017 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: ORTHOPEDICUROLOGY | ||||||
| 01/10/2017 | Egalet US Inc | SPRIX (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Pain Medicine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,654 | 3,009 | $1.4M | $217,863 |
| 2022 | 10 | 1,574 | 4,673 | $1.2M | $195,313 |
| 2021 | 13 | 1,628 | 4,378 | $944,822 | $206,077 |
| 2020 | 10 | 766 | 2,414 | $404,180 | $88,176 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 504 | 504 | $390,600 | $69,859 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 273 | 440 | $165,000 | $34,341 | 20.8% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 235 | 329 | $395,500 | $30,616 | 7.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 276 | $138,000 | $29,330 | 21.3% |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | Office | 2023 | 35 | 49 | $107,359 | $27,165 | 25.3% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2023 | 33 | 50 | $81,000 | $19,990 | 24.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 90 | 95 | $71,640 | $5,669 | 7.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 215 | 1,054 | $11,931 | $872.19 | 7.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 42 | 212 | $199.28 | $20.58 | 10.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 434 | 434 | $336,350 | $59,568 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 265 | 335 | $167,500 | $36,883 | 22.0% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2022 | 29 | 2,040 | $61,200 | $25,426 | 41.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 316 | $118,500 | $24,949 | 21.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 172 | 223 | $263,290 | $20,303 | 7.7% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2022 | 29 | 36 | $58,320 | $13,553 | 23.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 122 | 133 | $99,360 | $8,054 | 8.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 73 | 73 | $36,500 | $5,743 | 15.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 194 | 931 | $9,515 | $819.14 | 8.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 35 | 152 | $121.60 | $13.54 | 11.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 331 | 331 | $202,975 | $47,778 | 23.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 237 | 320 | $127,240 | $36,922 | 29.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 304 | 304 | $128,130 | $29,351 | 22.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 208 | 310 | $86,625 | $25,526 | 29.5% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2021 | 22 | 1,800 | $42,975 | $24,565 | 57.2% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 136 | 170 | $190,198 | $16,078 | 8.5% |
About Dr. Ryan Lingor, MD
Dr. Ryan Lingor, MD is a Sports Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2010. The National Provider Identifier (NPI) number assigned to this provider is 1215258470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Lingor, MD has received a total of $4,640 in payments from pharmaceutical and medical device companies, with $26.45 received in 2021. These payments were reported across 15 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($4,027).
As a Medicare-enrolled provider, Lingor has provided services to 5,622 Medicare beneficiaries, totaling 14,474 services with total Medicare billing of $707,430. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location New York, NY
- Active Since 06/22/2010
- Last Updated 02/01/2021
- Taxonomy Code 207QS0010X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215258470
Products in Payments
- Butterfly iQ (Device) $4,027
- Durolane (Device) $162.50
- TRITANIUM (Device) $141.57
- Coblation Wands (Device) $134.43
- Exogen (Device) $35.92
- ORTHOVISC (Device) $30.97
- Exogen Ultrasound Bone Healing System (Device) $26.45
- SPRIX (Drug) $24.42
- NO_PRODUCT (Drug) $23.50
- XIAFLEX (Biological) $21.67
- EUFLEXXA (Device) $11.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in New York
Seth Jerabek, M.d, M.D
Sports Medicine — Payments: $6.7M
Dr. Jose Rodriguez, M.d, M.D
Sports Medicine — Payments: $2.8M
Dr. Danyal Nawabi, M.d, M.D
Sports Medicine — Payments: $577,892
Dr. Steven Struhl, Md, MD
Sports Medicine — Payments: $455,106
Michael Fu, M.d, M.D
Sports Medicine — Payments: $175,715
Dr. Russell Warren, Md, MD
Sports Medicine — Payments: $151,297